Paper published in Rapid Communications in Mass Spectrometry “Correlated matrix-assisted laser desorption/ionization mass spectrometry and fluorescent imaging of photocleavable peptide-coded random bead-arrays” describing proteomic applications of Bead-AMS™
/in News, PIONEERING NEW TECHNOLOGIES /by Annmarie ThompsonPaper published in Journal of Immunological Methods “Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer” detailing the development of a serological assay for colorectal cancer biomarkers based on the novel use of the VeraCode™ multiplex bead assay system
/in News, PIONEERING NEW TECHNOLOGIES /by Annmarie ThompsonAmberGen receives US Patent 8,507,648 for novel method of detecting protease activity using mass spectrometry
/in News, PIONEERING NEW TECHNOLOGIES /by Annmarie ThompsonAmberGen receives US Patent 8,486,634 for novel method of detecting DNA methylation using solid-phase PCR
/in News, PIONEERING NEW TECHNOLOGIES /by Annmarie ThompsonAmberGen receives US Patent 8,481,263 for creating self-assembled bead-protein libraries by solid-phase PCR and nascent protein expression
/in News, PIONEERING NEW TECHNOLOGIES /by Annmarie ThompsonAmberGen receives US Patent 8,288,098 for a novel method of DNA sequencing using nucleotides having cleavable detectable labels
/in News, PIONEERING NEW TECHNOLOGIES /by Annmarie ThompsonAmberGen receives US Patent 8,278,045 for detecting chain truncation mutations which cause breast and colorectal cancer
/in News, PIONEERING NEW TECHNOLOGIES /by Annmarie ThompsonAmberGen receives US Patent 8,148,062 for detecting disease causing genetic mutations such as breast and colorectal cancer using affinity tags in translated nascent proteins
/in News, PIONEERING NEW TECHNOLOGIES /by Annmarie ThompsonAmberGen receives US Patent 8,114,587 for analyzing DNA mutations in fecal samples for colorectal cancer detection
/in News, PIONEERING NEW TECHNOLOGIES /by Annmarie ThompsonMenu
Menu 2
Recent News
- AmberGen announces that Dr. Michael Easterling, PhD will join Board of Directors
- AmberGen Announces New Appointments for John Gillespie & Dr. Kenneth J. Rothschild
- AmberGen and Bruker Collaborate on Spatial Biology Imaging Reagents for MALDI-Immunohistochemistry (MALDI-IHC)
- Dr. Mark Lim of AmberGen was honored to be an invited keynote speaker at the “Innovation in Mass Spectrometry Imaging Omics” Session